Piper Jaffray & Co. maintains a 'Buy' on ABIOMED, Inc. (Nasdaq: ABMD), raises price target from $8 to $10.

Piper ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE